David Jaskierny, MD
Anatomic Pathology & Clinical Pathology · Omaha, NENPI 1205913126
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Johnson & Johnson at 28.7% of the total. Reporting peaked in 2023 at $152 and has fallen 90.1% since, to $15 in 2024.
Across 20 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$89
- Dendreon Pharmaceuticals LLC$47
- Urovant Sciences Inc$30
- AstraZeneca$25
- Foundation Medicine, Inc.$23
- Accord Healthcare, Inc.$21
- plus $77 from 5 others
What the payments were for
- Food & beverage$312100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 6 | $89 |
| Dendreon Pharmaceuticals LLC | 3 | $47 |
| Urovant Sciences Inc | 2 | $30 |
| AstraZeneca | 2 | $25 |
| Foundation Medicine, Inc. | 1 | $23 |
| Accord Healthcare, Inc. | 1 | $21 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Bayer | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Amgen | 1 | $13 |
| Urogen Pharma, Inc. | 1 | $13 |
How this compares
$312 in reported general payments places this provider in the 80th percentile of 83 anatomic pathology & clinical pathology providers in Nebraska.
See all anatomic pathology & clinical pathology providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Omaha
- Scott KoepsellOmaha$117K
- Samuel CohenOmaha$16K
- Chunyan LiuOmaha$16K
- Jill HagenkordOmaha$12K
- Sadiq ZamanOmaha$5K
- Poonam SharmaOmaha$4K
- Carmelita AlvaresOmaha$1K
- Justin MiskoOmaha$1K
- Teresa KarreOmaha$956
- Timothy GreinerOmaha$906
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.